Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Prostate Cancer Diagnostics Market Be Worth By 2029?
The size of the prostate cancer diagnostics market has seen a swift expansion in the past few years. It is anticipated to increase from $4.43 billion in 2024 to $5.02 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.3%. The surge during the historic period could be due to the rise of the aging population, progression in medical imaging technology, heightened awareness and screening campaigns, public health strategies and enhancements in biopsy procedures.
In the coming years, the prostate cancer diagnostics market size is projected to experience substantial growth. It is expected to reach $8.13 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%. Factors contributing to the growth during the projected period include the adoption of artificial intelligence (AI), the expansion of telemedicine for cancer screenings, advancements in genomic profiling, patient-focused approaches, and the use of multiparametric MRI for diagnostics. The forecast period is expected to see significant trends, such as liquid biopsy technologies, advancements in detecting biomarkers, clinical research and development, integration of digital pathology, and the emergence of multiplex biomarker assays.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12003&type=smp
What Market Forces Are Contributing To The Growth Of The Prostate Cancer Diagnostics Market?
The escalating occurrence of prostate cancer is predicted to stimulate the expansion of the prostate cancer diagnostics market in the future. Prostate cancer is a disease that begins in the prostate gland, which is a part of both the male and female reproductive systems. Prostate cancer diagnostics are crucial for early detection of the disease using various methods such as prostate-specific antigen (PSA) testing and advanced imaging techniques. As an example, the American Cancer Society (ACS), a US-based organization committed to the eradication of cancer, reported approximately 288,300 new prostate cancer cases and 34,700 deaths from prostate cancer in January 2023. Consequently, the rising occurrence of prostate cancer is projected to spur the expansion of the prostate cancer diagnostics market.
Which Segments Define The Structure Of The Prostate Cancer Diagnostics Market?
The prostate cancer diagnosticsmarket covered in this report is segmented –
1) By Products: Instruments; Reagents And Consumables; Accessories
2) By Test Type: Preliminary Tests; Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer; Small Cell Carcinoma; Transitional Cell Cancer; Prostatic Adenocarcinoma; Ductal Adenocarcinoma; Small Cell Prostate Cancer; Acinar Adenocarcinoma
4) By Peer Groups: Adult; Pediatric; Geriatrics
5) By End User: Hospitals; Independent Diagnostic Laboratories; Cancer Research Institutes; Other End-Users
Subsegments:
1) By Instruments: Biopsy Instruments; Imaging Devices; Digital Rectal Examination Tools
2) By Reagents And Consumables: Diagnostic Assay Kits; Staining Reagents; Sample Collection Materials
3) By Accessories: Biopsy Guides; Specimen Handling Accessories; Calibration And Maintenance Tools
What Strategic Shifts And Innovations Are Influencing The Prostate Cancer Diagnostics Market?
The drive towards incorporation of technological advances is a key trend being observed in the prostate cancer diagnostic market. Mainstream companies in this market are striving to maintain their competitive edge through the launch of innovative diagnostic tools powered by artificial intelligence. For instance, in March 2023, Qritive, a firm based in Singapore known for developing diagnostic tools, unveiled its advanced AI-driven prostate cancer diagnosis tool named QAi Prostate. This tool employs sophisticated machine learning algorithms to pinpoint the prostatic adenocarcinoma region and examine the entire slide images of prostate core needle biopsies. Such innovations assist pathologists in rendering precise diagnoses more rapidly, thereby reducing the duration taken for treatment.
Which Firms Are Making The Biggest Impact In The Prostate Cancer Diagnostics Market?
Major companies operating in the prostate cancer diagnostics market include F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc, Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc, NeoGenomics Laboratories Inc., Guardant Health Inc, GRAIL Inc, Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd, Exosome Diagnostics Inc., Dana-Farber Cancer Institute, Cellanyx Diagnostics Inc., A3P Biomedical AB
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
Which Region Is Forecasted To Lead The Prostate Cancer Diagnostics Market In The Coming Years?
North America was the largest region in the prostate cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12003&type=smp
Browse Through More Reports Similar to the Global Prostate Cancer Diagnostics Market 2025, By The Business Research Company
Semiconductor Machinery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/semiconductor-machinery-global-market-report
Machinery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/machinery-global-market-report
Agriculture Construction And Mining Machinery Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model